Form 4 for DGX Quest Diagnostics
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001022079-23-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | DGX | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $147.86 | +9,917 | 77.7K | +15% | +$1.47M | |
| 2023-03-08 | 2023-03-07 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $140.55 | -5,307 | 67.8K | -7% | -$745.9K | |
| 2023-03-08 | 2023-03-06 | DGX | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $147.86 | -4,610 | 73.1K | -6% | -$681.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 9,917 | $147.86 | 77,727 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-07 | S | D | 5,307 | $140.55 | 67,810 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-06 | F | D | 4,610 | $147.86 | 73,117 | D | — | — |